| Project/Area Number |
20590840
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Circulatory organs internal medicine
|
|---|
| Research Institution | Juntendo University |
|---|
Principal Investigator |
INOUE Kenji (INOUE Kenii) 順天堂大学, 医学部, 准教授 (80317388)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SUWA Satoru 順天堂大学, 医学部, 先任准教授 (90226613)
|
|---|
| Project Period (FY) |
2008 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2011: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2010: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
|---|
| Keywords | バイオマーカー / 急性冠症候群 / 胸痛 / 睡眠時無呼吸症候群 / 臨床 / 動脈硬化 |
|---|
| Research Abstract |
In Japan as well as industry countries, the mortality caused by cardiovascular disease is worst. General practitioners are expected to make a diagnosis of such disease although they are not cardiologist. ECG or UCG are useful tools to make a diagnosis for such disease, but still, they require specific technique to make a diagnosis. We established a novel cardiovascular marker, Pentraxin 3 (PTX3). Only 0.1mL blood sample reflect the status of the inflammation of vascular. In this study, we have reported that PTX3 was a useful marker to predict the prognosis for patients with acute coronary syndrome, or sleep apnea syndrome.
|
